MedTrace Logo

A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures

NCT00297349 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 153

Last updated 2010-04-27

No results posted yet for this study

Summary

The purpose of this observational study is to evaluate the safety of topiramate when used in combination with other medications for seizures in adults and children.

Conditions

Interventions

DRUG

Topiramate

Individualization of the treatment should begin from 25 mg for 1 week.

Sponsors & Collaborators

  • Janssen Cilag Pharmaceutica S.A.C.I., Greece

    lead INDUSTRY

Principal Investigators

  • Janssen-Cilag Pharmaceutica S.A.C.I. Clinical Trial · Janssen-Cilag Pharmaceutica S.A.C.I.

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-11-30
Completion
2005-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00297349 on ClinicalTrials.gov